SREBP2-dependent cholesterol biosynthesis was activated and required for CRC liver metastasis after orthotropic injection of HT29 CRC cells, such that SREBP2-dependent cholesterol biosynthesis was induced by the activation of the PI3K/mTOR/AKT pathway in the liver [49]. The gene discussed is MTOR; the disease is colorectal carcinoma.